“…When designing a drug formulation for use in dentistry, it is necessary to consider aspects of the application of the carrier in the oral cavity, which is a diverse area and includes the lips, cheeks, the dorsal and lower surface of the tongue, hard palate, soft palate, maxillary and mandibular alveolar processes (gums), and the floor of the mouth, covered by a mucous membrane that is constantly moistened and flushed with saliva [1]. When developing therapeutic formulations for topical application in the oral cavity, it is necessary to take into account the leaching of the drug carrier by saliva, the poor penetration of the drug into the tissue, the limited adhesion surface of the preparation, its taste, the possibility of accidental ingestion of the carrier, and the aforementioned specificity of the site of application, or the disease entity being treated, i.e., therapy for lesions involving more superficial layers of epithelium, e.g., therapy for pseudomembranous candidiasis, or therapy for lesions requiring deeper penetration of the substance, e.g., therapy for Wilson's lichen and other mucocutaneous diseases [1][2][3][4][5][6][7]. In addition, there is the need for direct administration of the drug into periodontal pockets when supplemented mechanical therapy pocket cleaning is indicated [2].…”